A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery

被引：0
|
作者：
Kahn, Ryan [1 ]
Boerner, Thomas
An, Anjile [1 ]
Gardner, Ginger [1 ]
Roche, Kara Long [1 ]
Sonoda, Yukio [1 ]
Zivanovic, Oliver [1 ]
Grisham, Rachel [1 ]
Abu-Rustum, Nadeem [1 ]
Chi, Dennis [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [31] Chemotherapy delay after primary debulking surgery for ovarian cancer
    Seagle, Brandon-Luke L.
    Butler, Sharlay K.
    Strohl, Anna E.
    Nieves-Neira, Wilberto
    Shahabi, Shohreh
    GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 260 - 265
  • [32] National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery
    Jones, Nathaniel L.
    Chen, Ling
    Chatterjee, Sudeshna
    Tergas, Ana I.
    Burke, William M.
    Hou, June Y.
    Ananth, Cande V.
    Neugut, Alfred I.
    Hershman, Dawn L.
    Wright, Jason D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 19 - 25
  • [33] Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
    Alexandre A. B. A. da Costa
    Camila V. Valadares
    Glauco Baiocchi
    Henrique Mantoan
    Augusto Saito
    Solange Sanches
    Andréia P. Guimarães
    Maria Isabel W. Achatz
    Annals of Surgical Oncology, 2015, 22 : 971 - 978
  • [34] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [35] Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
    da Costa, Alexandre A. B. A.
    Valadares, Camila V.
    Baiocchi, Glauco
    Mantoan, Henrique
    Saito, Augusto
    Sanches, Solange
    Guimaraes, Andreia P.
    Achatz, Maria Isabel W.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S971 - S978
  • [36] Operative risk and preoperative hematocrit in bypass graft surgery: Role of gender and blood transfusion
    Ad, Niv
    Holmes, Sari D.
    Massimiano, Paul S.
    Spiegelstein, Dan
    Shuman, Deborah J.
    Pritchard, Graciela
    Halpin, Linda
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2015, 16 (07) : 397 - 400
  • [37] The Value of Ureteric Stents in Debulking Surgery for Disseminated Ovarian Cancer
    Ang, Christine
    Naik, Raj
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 978 - 980
  • [38] Splenectomy as a part of debulking surgery in patients with advanced ovarian cancer
    Derlatka, Pawel
    Grabowska-Derlatka, Laretta
    Sienko, Jacek
    Danska-Bidzinska, Anna
    GINEKOLOGIA POLSKA, 2014, 85 (08) : 605 - 608
  • [39] Estimating the Risk of Ovarian Cancer
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2009, 80 (06) : 632 - 634
  • [40] CLINICAL BENEFITS OF SECONDARY DEBULKING SURGERY FOR RECURRENT OVARIAN CANCER
    Furusawa, A.
    Uno, M.
    Mori, M.
    Kino, N.
    Ozaki, Y.
    Kubota, T.
    Yasugi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 151 - 151
12345